trial

Acceptability and Feasibility of MOL in Acute Inpatient Units

NCTId NCT05377294
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 14 (actual)
Sponsored by University of Manchester
Primary completion 2023-01-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
14 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2022-08-10
Primary completion
2023-01-30
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Method of Levels therapy

Sponsors

University of ManchesterLead Sponsor

Investigators

2
Sara Tai, DClinPsyPrincipal Investigator
Yvonne Awenat, PhDPrincipal Investigator

Sites

2 total
Manchester, United KingdomManchester, United Kingdom

Facts & assertions

4 sourced
Enrollment
14
Phase
NA
Primary Completion Date
2023-01-30
Status
COMPLETED
relationships
The graph out of here
drug
Method of Levels therapy
drug
lead_sponsor
University of Manchester
company
indication
Psychosis
indication
Suicidal
indication
Psychotic Disorders
indication
investigator
Sara Tai, DClinPsy
person
Yvonne Awenat, PhD
person